Coinfection with hepatitis C virus among HIV-positive people in the Kathmandu Valley, Nepal

Journal of the International Association of Providers of AIDS Care

Volumn 13, Issue 3, 2014, Pages 277-283

  Poudel, Krishna C ^a   Palmer, Paula H ^b   Jimba, Masamine ^c   Mizoue, Tetsuya ^d   Kobayashi, Jun ^d,e   Poudel Tandukar, Kalpana ^f  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b CLAREMONT GRADUATE UNIVERSITY   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f WASEDA UNIVERSITY   (Japan)

Author keywords

antiretroviral therapy; coinfection; HCV; HIV; Nepal

Indexed keywords

HEPATITIS ANTIBODY;

ADULT; ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; NEPAL; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; YOUNG ADULT;

ANTIRETROVIRAL THERAPY; COINFECTION; HCV; HIV; NEPAL;

ADULT; ANTI-RETROVIRAL AGENTS; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPAL; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84897423264     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413500989     Document Type: Article

References (40)

1. AIDS Epidemic Update: December 2009. Geneva, Switzerland: UNAIDS/WHO ; 2009 :
2. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010 ; 85 (1). 303-315
3. Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol. 2009 ; 83 (15). 7366-7374
4. Fuster D, Planas R, Muga R, et al. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy. AIDS Res Hum Retroviruses. 2004 ; 20 (12). 1293-1297
5. Jaggy C, von Overbeck J, Ledergerber B, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet. 2003 ; 362 (9387). 877-878
6. Barreiro P, Labarga P, Martín-Carbonero L, et al. Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients. Antivir Ther. 2006 ; 11 (7). 869-877
7. Soriano V, Labarga P, Ruiz-Sancho A, Garcia-Samaniego J, Barreiro P. Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin. AIDS. 2006 ; 20 (17). 2225-2227
8. Labarga P, Soriano V, Vispo ME, et al. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. J Infect Dis. 2007 ; 196 (5). 670-676
9. Segurado AC, Braga P, Etzel A, Cardoso MR, Hepatitis C. virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS. 2004 ; 18 (3). 135-143
10. Nagmoti MB, Patil CS, Jyoti MN, Mutnal MB, Mallapur MD. Prevalence of hepatitis C infection in HIV-seropositive individuals in and around Belgaum, South India. Int J STD AIDS. 2012 ; 23 (10). e14 - e15
11. Shang H, Zhong P, Liu J, et al. High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS ONE. 2010 ; 5 (5). e10631
12. Wolff FH, Fuchs SC, Barcellos NT, et al. Risk factors for hepatitis C virus infection in individuals infected with the HIV. Dig Liver Dis. 2008 ; 40 (6). 460-467
13. Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol. 2006 ; 12 (42). 6879-6883
14. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004 ; 5 (3). 174-179
15. Solomon SS, Srikrishnan AK, Mehta SH, et al. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr. 2008 ; 49 (3). 327-32
16. Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011 ; 8 (1). 12-22
17. Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc. 2011 ; 14: 22
18. Maek-a-Nantawat W, Avihingsanon A, Ohata PJ. Challenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settings. AIDS Res Treat. 2012 ; 948059: 2012
19. Srikantiah P, Ghidinelli M, Bachani D, et al. Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region. AIDS. 2010 ; 24 (suppl 3). S62 - S71
20. Zhang F, Haberer JE, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007 ; 21 (suppl 8). S143 - S148
21. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008 ; 22 ((15 )). 1897-1908
22. Nepal Country Progress Report 2012: To Contribute to Global AIDS Response Progress Report 2012. Kathmandu, Nepal: National Center for AIDS and STD Control ; 2012:
23. Shrestha SM, Subedi NB, Shrestha S, Maharjan KG, Tsuda F, Okamoto H. Epidemiology of hepatitis C virus infection in Nepal. Trop Gastroenterol. 1998 ; 19 (3). 102-104
24. HEPA Foundation, UNODC. Prevalence of Hepatitic C in OST Client. Kathmandu, Nepal: HEPA Foundation and United Nations Office on Drugs and Crime, 2009. http://www.recoveringnepal.org.np/image/info-materials/ 20111103081156838553767.pdf. Accessed March 22, 2013.
25. Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997 ; 35 (12). 3274-3277
26. National Antiretroviral Therapy Guidelines 2012. Kathmandu, Nepal: National Center for AIDS and STD Control ; 2012:
27. Poudel-Tandukar K, Poudel KC, Jimba M, Kobayashi J, Johnson CA, Palmer PH AIDS Research Human Retroviruses. 2013: 528-534.
28. Shrestha S, Poudel KC, Poudel-Tandukar K, et al J Int Assoc Provid AIDS Care.
29. Amiya RM, Poudel KC, Poudel-Tandukar K, Kobayashi J, Pandey BD, Jimba M BMC Public Health. 2011: 677.
30. Glossary, NHIS-Adult Tobacco Use Information. Atlanta, GA: Centers for Disease Control and Prevention ;
31. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000 ; 356 (9244). 1800-1805
32. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000 ; 20 (1). 1-16
33. Kim AY, Onofrey S, Church DR. An epidemiologic update on Hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis. 2013 ; 207 (suppl 1). S1 - S6
34. Viral Hepatitis: Global Policy. 2011.
35. World Health Organization, International Agency for Research on Cancer. Tobacco smoke. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC; 2004:49-1188. http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf. Accessed March 22, 2013.
36. Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol. 2009 ; 38 (6). 1497-1511
37. Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010 ; 19 (5). 1261-1268
38. Fiore RJ, Potenza D, Monno L, et al. Detection of HCV RNA in serum and seminal fluid from HIV-1 co-infected intravenous drug addicts. J Med Virol. 1995 ; 46 (4). 364-367
39. Nyamathi A, Robbins WA, Fahey JL, et al. Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs. 2002 ; 4 (1). 22-30
40. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001 ; 33 (4). 562-569